Income Statement (TTM)
Lionco Pharmaceutical Group Co.,Ltd. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,194 | 1,001 | 1,015 | 1,005 | 885 | 740 | 592 | 463 | 338 | 289 | 237 | 202 | 189 | 197 | 200 | 225 | 277 | 380 | 353 | 410 |
| Change (%) | -16.14 | 1.43 | -1.00 | -11.96 | -16.35 | -19.99 | -21.89 | -27.04 | -14.31 | -18.22 | -14.65 | -6.53 | 4.30 | 1.81 | 12.48 | 22.99 | 37.01 | -7.04 | 16.11 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 176 | 165 | 166 | 171 | 167 | 156 | 143 | 114 | 100 | 95 | 94 | 118 | 115 | 110 | 115 | 130 | 162 | 207 | 210 | 270 |
| Change (%) | -6.20 | 0.39 | 3.22 | -2.57 | -6.81 | -8.16 | -20.56 | -11.90 | -5.56 | -0.47 | 25.39 | -2.42 | -4.55 | 4.97 | 12.72 | 24.74 | 27.34 | 1.48 | 28.73 | |
| % of Revenue | 14.78 | 16.53 | 16.36 | 17.06 | 18.88 | 21.03 | 24.14 | 24.55 | 29.65 | 32.68 | 39.77 | 58.43 | 61.00 | 55.82 | 57.55 | 57.68 | 58.51 | 54.38 | 59.37 | 65.82 |
| Gross Operating Profit | 1,017 | 836 | 849 | 834 | 718 | 585 | 449 | 349 | 237 | 195 | 142 | 84 | 74 | 87 | 85 | 95 | 115 | 173 | 143 | 140 |
| Change (%) | -17.86 | 1.63 | -1.82 | -13.89 | -18.56 | -23.14 | -22.32 | -31.97 | -18.00 | -26.83 | -41.09 | -12.31 | 18.14 | -2.19 | 12.14 | 20.59 | 50.63 | -17.20 | -2.33 | |
| % of Revenue | 85.22 | 83.47 | 83.64 | 82.94 | 81.12 | 78.97 | 75.86 | 75.45 | 70.35 | 67.32 | 60.23 | 41.57 | 39.00 | 44.18 | 42.45 | 42.32 | 41.49 | 45.62 | 40.63 | 34.18 |
| SG&A | 848 | 699 | 708 | 694 | 596 | 514 | 403 | 295 | 305 | 334 | 325 | 328 | 250 | 223 | 215 | 215 | 219 | 251 | 214 | 207 |
| Change (%) | -17.59 | 1.25 | -1.93 | -14.19 | -13.74 | -21.56 | -26.82 | 3.41 | 9.47 | -2.62 | 0.82 | -23.61 | -11.02 | -3.43 | -0.05 | 1.69 | 14.81 | -14.58 | -3.30 | |
| % of Revenue | 71.08 | 69.84 | 69.72 | 69.06 | 67.31 | 69.40 | 68.04 | 63.74 | 90.35 | 115.41 | 137.42 | 162.34 | 132.67 | 113.19 | 107.37 | 95.42 | 78.90 | 66.11 | 60.75 | 50.59 |
| R&D | 16 | 20 | 18 | 21 | 26 | 23 | 22 | 21 | 22 | 32 | 33 | 34 | 35 | 29 | 30 | 26 | 23 | 27 | 26 | 21 |
| Change (%) | 27.10 | -9.24 | 15.05 | 22.52 | -12.59 | -3.27 | -4.11 | 4.03 | 43.91 | 5.16 | 3.06 | 2.10 | -16.77 | 4.47 | -13.03 | -13.52 | 16.51 | -3.60 | -18.09 | |
| % of Revenue | 1.34 | 2.03 | 1.82 | 2.12 | 2.94 | 3.08 | 3.72 | 4.57 | 6.51 | 10.93 | 14.06 | 16.97 | 18.54 | 14.80 | 15.18 | 11.74 | 8.26 | 7.02 | 7.28 | 5.14 |
| OpEx | 1,008 | 898 | 939 | 933 | 864 | 702 | 577 | 436 | 458 | 466 | 457 | 480 | 371 | 367 | 361 | 381 | 426 | 489 | 460 | 503 |
| Change (%) | -10.90 | 4.53 | -0.60 | -7.42 | -18.77 | -17.86 | -24.33 | 4.88 | 1.91 | -2.04 | 5.08 | -22.68 | -1.17 | -1.63 | 5.69 | 11.81 | 14.70 | -5.87 | 9.37 | |
| % of Revenue | 84.48 | 89.74 | 92.49 | 92.86 | 97.65 | 94.81 | 97.33 | 94.29 | 135.55 | 161.20 | 193.10 | 237.75 | 196.68 | 186.36 | 180.06 | 169.19 | 153.82 | 128.77 | 130.39 | 122.82 |
| Operating Income | 185 | 103 | 76 | 72 | 21 | 38 | 16 | 26 | -120 | -177 | -220 | -278 | -182 | -170 | -160 | -156 | -149 | -109 | -107 | -94 |
| Change (%) | -44.60 | -25.69 | -5.92 | -70.97 | 84.42 | -58.81 | 66.83 | -554.52 | 47.53 | 24.40 | 26.28 | -34.40 | -6.83 | -5.62 | -2.79 | -4.34 | -26.75 | -1.82 | -12.79 | |
| % of Revenue | 15.52 | 10.26 | 7.51 | 7.14 | 2.35 | 5.19 | 2.67 | 5.71 | -35.55 | -61.20 | -93.10 | -137.75 | -96.68 | -86.36 | -80.06 | -69.19 | -53.82 | -28.77 | -30.39 | -22.82 |
| Interest Expense | -14 | -11 | -14 | -15 | -14 | -16 | -14 | -12 | -11 | -6 | -4 | -3 | -3 | -4 | -3 | -3 | -7 | -27 | -32 | -36 |
| Change (%) | -18.28 | 21.03 | 9.32 | -4.22 | 8.79 | -10.65 | -10.92 | -13.94 | -45.11 | -25.78 | -31.22 | -7.18 | 34.26 | -26.80 | 18.97 | 125.02 | 276.58 | 17.91 | 11.87 | |
| % of Revenue | -1.15 | -1.12 | -1.34 | -1.48 | -1.61 | -2.10 | -2.34 | -2.67 | -3.15 | -2.02 | -1.83 | -1.47 | -1.46 | -1.88 | -1.36 | -1.43 | -2.62 | -7.21 | -9.14 | -8.81 |
| Net Income | 203 | 160 | 129 | 153 | 87 | 66 | 51 | 33 | -82 | -196 | -239 | -301 | -223 | -151 | -145 | -122 | -102 | -131 | -133 | -126 |
| Change (%) | -21.24 | -19.31 | 18.11 | -43.24 | -23.90 | -22.07 | -35.73 | -349.81 | 137.54 | 22.24 | 25.92 | -26.04 | -32.06 | -4.59 | -15.48 | -16.67 | 28.45 | 1.97 | -5.43 | |
| % of Revenue | 17.03 | 15.99 | 12.72 | 15.18 | 9.79 | 8.90 | 8.67 | 7.13 | -24.43 | -67.71 | -101.20 | -149.31 | -118.15 | -76.97 | -72.13 | -54.21 | -36.73 | -34.43 | -37.77 | -30.76 |
Source: Capital IQ
